Precision Healthcare

Population-based RCT trial, meta-analysis, and cost-effectiveness analysis on universal screening strategy before is to aggregate individual into average-risk level; Using precision screening based on risk spectrum, we may have a Win-Win policy for reducing false positives and false negatives simultaneously.